Belatacept®, une nouvelle molécule originale, immunosuppressive, en transplantation d’organe

Medecine/Sciences

Volumn 22, Issue 4, 2006, Pages 354-355

  Beaudreuil, Séverine ^a   Durrbach, Antoine ^a   Kriaa, Faycal ^a   Charpentier, Bernard ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ANTIBODY CONJUGATE; B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CHEMICAL STRUCTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DRUG EFFECT; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PHYSIOLOGY; PROTEIN CONFORMATION; PROTEIN TERTIARY STRUCTURE; RANDOMIZED CONTROLLED TRIAL;

ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD86; CYTOTOXICITY, IMMUNOLOGIC; GRAFT REJECTION; GRAFT VS HOST DISEASE; HUMANS; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; MODELS, MOLECULAR; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; RANDOMIZED CONTROLLED TRIALS; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION IMMUNOLOGY;

EID: 33746223258     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/2006224354     Document Type: Article

References (9)

1. Vincenti F, Ramos E, Brattstrom C, et al. Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation. Transplantation 2001; 71: 1282-7.
2. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a non renal organ. N Engl J Med 2003; 349: 931-40.
3. Sayegh MH, Turka LA. The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 1998; 338: 1813-21.
4. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allograft after blocking CD40 and CD28 pathways. Nature 1996; 381: 434-8.
5. Lenschow DJ, Zeng Y, Thistlethwaite JR, et al. Longterm survival of xenogenic pancreatic islet grafts induced by CTLA4Ig. Science 1992; 257: 789-92.
6. Turka LA, Linsley PS, Lin H, et al. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci USA 1992; 89: 11102-5.
7. Pearson TC, Alexander DZ, Winn KJ, et al. Transplantation tolerance induced by CTLA4-Ig. Transplantation 1994; 57: 1701-6.
8. Pearson TC, Alexander DZ, Corbascio M, et al. Analysis of the B7 costimulatory pathway in allograft rejection. Transplantation 1997; 63: 1463-9.
9. Vincenti F, Larsen C, Durrbach A, et al. Costimulation blockade with belatacept in renal transplantation. N Engl J Med 2005; 353: 770-81.